A Phase Ib/II Study of Gemcitabine and Docetaxel in Combination With Pazopanib for the Neoadjuvant Treatment of Soft Tissue Sarcomas

LESSONS LEARNED: Our results highlight some of the challenges in the management of soft tissue sarcomas, which requires close cooperation between surgeons and medical oncologists and a careful selection of patients. The incidence of hepatotoxicity was a concerning finding and had been previously rep...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Oncologist
Auteurs principaux: Munhoz, Rodrigo R., D’Angelo, Sandra P., Gounder, Mrinal M., Keohan, Mary L., Chi, Ping, Carvajal, Richard D., Singer, Samuel, Crago, Aimee M., Landa, Jonathan, Healey, John H., Qin, Li-Xuan, Hameed, Meera, Ezeoke, Marietta O., Singh, Arun S., Agulnik, Mark, Chmielowski, Bartosz, Luke, Jason J., Van Tine, Brian A., Schwartz, Gary K., Tap, William D., Dickson, Mark A.
Format: Artigo
Langue:Inglês
Publié: AlphaMed Press 2015
Sujets:
Clinical Trial Results
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC4718433/
https://ncbi.nlm.nih.gov/pubmed/26449382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2015-0245
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires